Archrock, Inc. (AROC) capitalization

Current snapshot

Market Cap
$6.10B
175.3M shares × $34.80 · as of last filing 2026-03-31
Net Worth
$1.52B
Stockholders' equity · 2026-03-31
Enterprise Value
$8.48B
Market cap + debt − cash
Net Debt
$2.38B
Debt $2.39B − Cash $4.5M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $4.55B
FY'24 2024-12-31 $4.04B
FY'23 2023-12-31 $2.38B
FY'22 2022-12-31 $1.38B
FY'21 2021-12-31 $1.14B
FY'20 2020-12-31 $1.31B
FY'19 2019-12-31 $1.38B
FY'18 2018-12-31 $819.6M
FY'17 2017-12-31 $731.5M
FY'16 2016-12-31 $910.7M
FY'15 2015-12-31 $514.6M
FY'14 2014-12-31 $2.16B
FY'13 2013-12-31 $2.20B
FY'12 2012-12-31 $1.39B
FY'11 2011-12-31 $569.9M
FY'10 2010-12-31 $1.48B
FY'10 2009-12-31 $1.32B
FY'10 2008-12-31 $1.38B

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $6.07B
Q4'25 2025-12-31 $4.55B
Q3'25 2025-09-30 $4.60B
Q2'25 2025-06-30 $4.35B
Q1'25 2025-03-31 $4.58B
Q4'24 2024-12-31 $4.36B
Q3'24 2024-09-30 $3.36B
Q2'24 2024-06-30 $3.13B
Q1'24 2024-03-31 $3.04B
Q4'23 2023-12-31 $2.55B
Q3'23 2023-09-30 $1.95B
Q2'23 2023-06-30 $1.58B
Q1'23 2023-03-31 $1.51B
Q4'22 2022-12-31 $1.41B
Q3'22 2022-09-30 $986.7M
Q2'22 2022-06-30 $1.27B
Q1'22 2022-03-31 $1.41B
Q4'21 2021-12-31 $1.16B
Q3'21 2021-09-30 $1.26B
Q2'21 2021-06-30 $1.36B
Q1'21 2021-03-31 $1.44B
Q4'20 2020-12-31 $1.32B
Q3'20 2020-09-30 $812.6M
Q2'20 2020-06-30 $978.3M
Q1'20 2020-03-31 $566.1M
Q4'19 2019-12-31 $1.53B
Q3'19 2019-09-30 $1.43B
Q2'19 2019-06-30 $1.36B
Q1'19 2019-03-31 $1.25B
Q4'18 2018-12-31 $976.8M
Q3'18 2018-09-30 $1.56B
Q2'18 2018-06-30 $1.34B
Q1'18 2018-03-31 $611.8M
Q1'18 2018-01-01
Q4'17 2017-12-31 $745.0M
Q3'17 2017-09-30 $874.0M
Q2'17 2017-06-30 $793.3M
Q1'17 2017-03-31 $860.6M
Q4'16 2016-12-31 $931.1M
Q3'16 2016-09-30 $903.4M
Q2'16 2016-06-30 $650.2M
Q1'16 2016-03-31 $550.7M
Q4'15 2015-12-31 $523.6M
Q3'15 2015-09-30 $1.23B
Q2'15 2015-06-30 $2.24B
Q1'15 2015-03-31 $2.29B
Q4'14 2014-12-31 $2.25B
Q3'14 2014-09-30 $3.12B
Q2'14 2014-06-30 $2.96B
Q1'14 2014-03-31 $2.87B
Q4'13 2013-12-31 $2.26B
Q3'13 2013-09-30 $1.80B
Q2'13 2013-06-30 $1.83B
Q1'13 2013-03-31 $1.74B
Q4'12 2012-12-31 $1.42B
Q3'12 2012-09-30 $1.32B
Q2'12 2012-06-30 $809.3M
Q1'12 2012-03-31 $852.0M
Q4'11 2011-12-31 $584.9M
Q3'11 2011-09-30 $609.7M
Q2'11 2011-06-30 $1.24B
Q1'11 2011-03-31 $1.48B
Q4'10 2010-12-31 $1.51B
Q3'10 2010-09-30 $1.41B
Q2'10 2010-06-30 $1.60B
Q1'11 2010-03-31 $1.51B
Q4'10 2009-12-31 $1.32B
Q3'10 2009-09-30 $1.84B
Q2'10 2009-06-30 $982.9M

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (AROC CIK 0001389050), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

NYT

THE NEW YORK TIMES COMPANY

WY

WEYERHAEUSER COMPANY

ESPR

Esperion Therapeutics, Inc.